47-second trade demo: how to make ANY bear market cough up cash

From Tradesmith | Ad

It's a bloodbath out there. But while most investors sweat bullets wondering what to do… (And where to find ANY safe haven for their money). Trading expert Keith Kaplan has created an "income loop" algorithm …that actually FORCES instant cash out of every trade. Click here to view a live "demo".

>>>

ARQT Insider Trading (Arcutis Biotherapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 23.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $19,494,103.32

Arcutis Biotherapeutics Insider Trading History Chart

Arcutis Biotherapeutics Share Price & Price History

^$21.49

▼ -0.63 (-2.85%)

As of 06/30/2022 03:40 PM ET

Days: 30 | 90 | 365

New Investing App Saves Investors an Average of $97,347

From Tradesmith | Ad

Most people are terrible at buying and selling stocks at the right time, but the TradeSmith app takes the emotion out of investing.

Our back test shows, the average investor would've made $97,347 more just by using the TradeSmith app analyzer software.

Check out this FREE video.

>>>

Arcutis Biotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/24/2022	Orbimed Advisors Llc	Major Shareholder	Sell	341,971	$21.31	$7,287,402.01	415,142
6/2/2022	Masaru Matsuda	SVP	Sell	1,795	$19.73	$35,415.35	16,380
6/1/2022	Howard G. Welgus	Director	Sell	2,500	$20.62	$51,550.00	181,896
5/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.76	$21,760.00	658,667
5/2/2022	Howard G. Welgus	Director	Sell	2,500	$20.44	$51,100.00	181,896
4/21/2022	David W Osborne	Insider	Sell	2,197	$20.42	$44,862.74	257,229
4/8/2022	Orbimed Advisors Llc	Major Shareholder	Sell	200,000	$20.71	$4,142,000.00
4/6/2022	Orbimed Advisors Llc	Major Shareholder	Sell	333,204	$20.69	$6,893,990.76
4/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.43	$21,430.00	659,667
4/1/2022	Howard G. Welgus	Director	Sell	7,500	$20.02	$150,150.00
3/9/2022	Todd Franklin Watanabe	CEO	Sell	300	$17.00	$5,100.00
3/7/2022	Patrick Burnett	Insider	Sell	30	$16.44	$493.20
3/7/2022	Scott L. Burrows	CFO	Sell	10	$16.44	$164.40
3/7/2022	Todd Franklin Watanabe	CEO	Sell	770	$17.05	$13,128.50
3/4/2022	Patricia A. Turney	SVP	Sell	993	$16.86	$16,741.98
3/4/2022	Patrick Burnett	Insider	Sell	981	$16.86	$16,539.66
3/4/2022	Scott L. Burrows	CFO	Sell	293	$16.86	$4,939.98
3/4/2022	Todd Franklin Watanabe	CEO	Sell	2,489	$16.86	$41,964.54
2/9/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$17.00	$17,000.00
1/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.59	$21,590.00
1/3/2022	Howard G. Welgus	Director	Sell	2,500	$21.21	$53,025.00
12/27/2021	Scott L. Burrows	CFO	Sell	12,560	$20.07	$252,079.20
12/23/2021	Howard G. Welgus	Director	Sell	2,500	$20.16	$50,400.00
12/8/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$17.00	$17,000.00
11/5/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$21.50	$21,500.00
11/1/2021	Howard G. Welgus	Director	Sell	2,500	$21.81	$54,525.00
10/5/2021	Todd Franklin Watanabe	CEO	Sell	2,500	$24.92	$62,300.00
9/7/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$21.14	$21,140.00
8/5/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$20.81	$20,810.00
7/6/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$26.58	$46,515.00
7/1/2021	Howard G. Welgus	Director	Sell	2,200	$26.13	$57,486.00
6/24/2021	Bhaskar Chaudhuri	Director	Sell	729	$27.50	$20,047.50	848,146
6/21/2021	Bhaskar Chaudhuri	Director	Sell	2,516	$27.50	$69,190.00	848,875
6/7/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$26.35	$46,112.50
5/7/2021	Todd Franklin Watanabe	CEO	Sell	750	$35.00	$26,250.00
5/5/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$34.00	$59,500.00
4/20/2021	Bhaskar Chaudhuri	Director	Sell	10,000	$28.06	$280,600.00	862,671
4/5/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$29.93	$52,377.50
4/1/2021	Howard G. Welgus	Director	Sell	2,200	$29.49	$64,878.00
3/22/2021	Bhaskar Chaudhuri	Director	Sell	10,000	$31.10	$311,000.00	876,383
3/5/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$30.55	$53,462.50
2/10/2021	John W. Smither	CFO	Sell	750	$35.64	$26,730.00
2/1/2021	Bhaskar Chaudhuri	Director	Sell	9,949	$33.25	$330,804.25	901,340
2/1/2021	John W. Smither	CFO	Sell	1,250	$35.00	$43,750.00
1/29/2021	Bhaskar Chaudhuri	Director	Sell	51	$27.50	$1,402.50	901,340
1/19/2021	John W. Smither	CFO	Sell	500	$30.00	$15,000.00
12/1/2020	Howard G. Welgus	Director	Sell	2,200	$25.98	$57,156.00	180,234
10/1/2020	Howard G. Welgus	Director	Sell	2,200	$27.65	$60,830.00	179,210
9/29/2020	David W. Osborne	Insider	Sell	15,000	$30.00	$450,000.00
9/29/2020	John W. Smither	CFO	Sell	500	$30.00	$15,000.00
9/29/2020	Todd Franklin Watanabe	CEO	Sell	3,000	$30.00	$90,000.00	569,928
9/1/2020	Howard G. Welgus	Director	Sell	2,200	$24.38	$53,636.00	178,378
8/3/2020	Howard G. Welgus	Director	Sell	2,800	$25.63	$71,764.00	162,725
2/4/2020	Life Sciences Viii L Frazier	Major Shareholder	Buy	500,000	$24.10	$12,050,000.00
2/3/2020	Jonathan Silverstein	Director	Buy	558,888	$25.64	$14,329,888.32

Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for Arcutis Biotherapeutics (NASDAQ:ARQT)

87.59% of Arcutis Biotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Arcutis Biotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/7/2022	Bank of America Corp DE	10,000	$0.19M	0.0%	-17.4%	0.019%
5/27/2022	Walleye Capital LLC	75,553	$1.46M	0.0%	-9.4%	0.147%
5/23/2022	Neuberger Berman Group LLC	129,276	$2.49M	0.0%	+5.9%	0.251%
5/17/2022	Walleye Capital LLC	75,553	$1.46M	0.0%	-9.4%	0.147%
5/17/2022	Jane Street Group LLC	14,398	$0.28M	0.0%	N/A	0.028%
5/17/2022	Quantbot Technologies LP	2,300	$44K	0.0%	N/A	0.004%
5/17/2022	Royal Bank of Canada	1,900	$37K	0.0%	-62.8%	0.004%
5/17/2022	Ensign Peak Advisors Inc	495,450	$9.54M	0.0%	+18.1%	0.964%
5/17/2022	Guggenheim Capital LLC	12,266	$0.24M	0.0%	+14.4%	0.024%
5/16/2022	California State Teachers Retirement System	33,524	$0.65M	0.0%	-7.6%	0.065%
5/16/2022	Goldman Sachs Group Inc.	62,573	$1.21M	0.0%	+29.7%	0.122%
5/16/2022	State Street Corp	1,189,500	$22.91M	0.0%	+6.2%	2.313%
5/16/2022	Frazier Life Sciences Management L.P.	8,434,232	$162.44M	13.8%	N/A	16.403%
5/16/2022	Hsbc Holdings PLC	91,988	$1.77M	0.0%	+166.5%	0.179%
5/13/2022	Northern Trust Corp	258,937	$4.99M	0.0%	-4.1%	0.504%
5/13/2022	Charles Schwab Investment Management Inc.	200,964	$3.87M	0.0%	+1.3%	0.391%
5/13/2022	American International Group Inc.	13,733	$0.26M	0.0%	-6.6%	0.027%
5/13/2022	Vanguard Group Inc.	1,531,098	$29.49M	0.0%	+1.1%	2.978%
5/13/2022	Dimensional Fund Advisors LP	227,383	$4.38M	0.0%	+83.5%	0.442%
5/12/2022	BlackRock Inc.	4,315,802	$83.12M	0.0%	+0.0%	8.394%
5/12/2022	Metropolitan Life Insurance Co NY	1,705	$33K	0.0%	-78.3%	0.003%
5/12/2022	MetLife Investment Management LLC	16,718	$0.32M	0.0%	+58.5%	0.033%
5/12/2022	Citigroup Inc.	11,603	$0.22M	0.0%	-90.4%	0.023%
5/12/2022	1492 Capital Management LLC	75,192	$1.45M	0.8%	N/A	0.146%
5/11/2022	American Century Companies Inc.	524,559	$10.10M	0.0%	+7.7%	1.020%
5/11/2022	Bank of New York Mellon Corp	96,346	$1.86M	0.0%	-1.2%	0.187%
5/11/2022	JPMorgan Chase & Co.	27,022	$0.52M	0.0%	+20.8%	0.053%
5/11/2022	GSA Capital Partners LLP	27,851	$0.54M	0.1%	N/A	0.054%
5/10/2022	Sectoral Asset Management Inc.	219,136	$4.22M	0.7%	-10.1%	0.426%
5/10/2022	ProShare Advisors LLC	10,401	$0.20M	0.0%	-20.8%	0.020%
5/9/2022	GW&K Investment Management LLC	212,500	$4.09M	0.0%	N/A	0.413%
5/9/2022	Swiss National Bank	59,500	$1.15M	0.0%	+7.8%	0.116%
5/6/2022	Los Angeles Capital Management LLC	26,257	$0.51M	0.0%	-6.1%	0.051%
4/29/2022	Nisa Investment Advisors LLC	13,900	$0.27M	0.0%	N/A	0.027%
4/28/2022	DekaBank Deutsche Girozentrale	14,000	$0.26M	0.0%	+10.2%	0.027%
4/26/2022	Hennion & Walsh Asset Management Inc.	87,369	$1.68M	0.1%	+33.7%	0.170%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	1,494	$29K	0.0%	N/A	0.003%
3/3/2022	Walleye Capital LLC	83,420	$1.73M	0.0%	N/A	0.166%
2/25/2022	AlphaCentric Advisors LLC	52,500	$1.09M	0.3%	N/A	0.104%
2/14/2022	Virtus ETF Advisers LLC	10,965	$0.23M	0.1%	+50.1%	0.022%
2/14/2022	Point72 Asset Management L.P.	2,644,177	$54.84M	0.2%	+32.7%	5.257%
2/11/2022	Ensign Peak Advisors Inc	419,674	$8.70M	0.0%	+7.6%	0.834%
2/10/2022	Rafferty Asset Management LLC	56,850	$1.18M	0.0%	+88.1%	0.113%
2/10/2022	Citigroup Inc.	120,240	$2.49M	0.0%	+382.2%	0.239%
2/10/2022	TD Asset Management Inc.	35,920	$0.75M	0.0%	+17.7%	0.071%
2/9/2022	Alps Advisors Inc.	58,203	$1.21M	0.0%	-5.5%	0.116%
2/9/2022	Wade G W & Inc.	13,100	$0.27M	0.0%	N/A	0.026%
2/9/2022	Dimensional Fund Advisors LP	123,906	$2.57M	0.0%	+56.1%	0.246%
2/8/2022	ProShare Advisors LLC	13,127	$0.27M	0.0%	-8.0%	0.026%
2/7/2022	SG Americas Securities LLC	8,251	$0.17M	0.0%	-58.3%	0.016%
2/7/2022	American Century Companies Inc.	487,071	$10.10M	0.0%	+29.5%	0.968%
2/4/2022	IndexIQ Advisors LLC	14,598	$0.30M	0.0%	-6.1%	0.029%
1/28/2022	Allspring Global Investments Holdings LLC	617,600	$12.81M	0.0%	N/A	1.228%
1/21/2022	Denali Advisors LLC	3,700	$77K	0.0%	N/A	0.007%
11/17/2021	Altium Capital Management LP	255,000	$6.09M	1.4%	+10.2%	0.507%
11/16/2021	Thrivent Financial for Lutherans	10,370	$0.25M	0.0%	N/A	0.021%
11/16/2021	Two Sigma Advisers LP	27,700	$0.66M	0.0%	-55.3%	0.055%
11/15/2021	Point72 Asset Management L.P.	1,992,107	$47.59M	0.2%	+122.2%	3.961%
11/15/2021	California State Teachers Retirement System	35,513	$0.85M	0.0%	-6.9%	0.071%
11/15/2021	Pura Vida Investments LLC	112,324	$2.68M	0.1%	-1.5%	0.223%
11/15/2021	AXA S.A.	259,084	$6.19M	0.0%	+6.5%	0.515%
11/15/2021	Polar Capital Holdings Plc	1,548,901	$37M	0.2%	-7.9%	3.080%
11/15/2021	Dimensional Fund Advisors LP	79,395	$1.89M	0.0%	+69.7%	0.158%
11/15/2021	Neuberger Berman Group LLC	122,087	$2.92M	0.0%	+0.7%	0.243%
11/15/2021	Ensign Peak Advisors Inc	389,938	$9.32M	0.0%	-1.8%	0.775%
11/15/2021	Franklin Resources Inc.	575,208	$13.74M	0.0%	-0.1%	1.144%
11/15/2021	Martingale Asset Management L P	11,803	$0.28M	0.0%	N/A	0.023%
11/12/2021	The Manufacturers Life Insurance Company	14,911	$0.36M	0.0%	-7.5%	0.030%
11/12/2021	Geode Capital Management LLC	488,855	$11.68M	0.0%	+2.9%	0.972%
11/12/2021	Hennion & Walsh Asset Management Inc.	30,596	$0.73M	0.0%	+52.1%	0.061%
11/10/2021	American Century Companies Inc.	376,074	$8.99M	0.0%	-0.1%	0.749%
11/10/2021	Goldman Sachs Group Inc.	40,627	$0.97M	0.0%	+27.9%	0.081%
11/10/2021	IndexIQ Advisors LLC	15,541	$0.37M	0.0%	+11.1%	0.031%
11/10/2021	Citigroup Inc.	24,936	$0.60M	0.0%	-59.4%	0.050%
11/10/2021	Rafferty Asset Management LLC	30,223	$0.72M	0.0%	-20.0%	0.060%
11/9/2021	BlackRock Inc.	4,195,926	$100.24M	0.0%	-1.2%	8.343%
11/9/2021	Principal Financial Group Inc.	9,951	$0.24M	0.0%	-13.9%	0.020%
11/8/2021	Los Angeles Capital Management LLC	27,970	$0.67M	0.0%	+4.8%	0.056%
11/5/2021	Penn Mutual Asset Management LLC	5,413	$0.13M	0.2%	N/A	0.011%
11/4/2021	Deutsche Bank AG	16,087	$0.38M	0.0%	-10.8%	0.032%
11/2/2021	New York State Common Retirement Fund	18,995	$0.45M	0.0%	-20.5%	0.038%
11/1/2021	SG Americas Securities LLC	19,783	$0.47M	0.0%	-20.4%	0.039%
10/14/2021	Hamilton Lane Advisors LLC	52,347	$1.25M	0.2%	-48.3%	0.104%
8/25/2021	Marshall Wace LLP	15,138	$0.41M	0.0%	-91.1%	0.030%
8/17/2021	Wells Fargo & Company MN	897,972	$24.51M	0.0%	+2.4%	1.787%
8/17/2021	Metropolitan Life Insurance Co NY	7,875	$0.22M	0.0%	+131,150.0%	0.016%
8/17/2021	MetLife Investment Management LLC	10,548	$0.29M	0.0%	+27.9%	0.021%
8/17/2021	Price T Rowe Associates Inc. MD	924,958	$25.24M	0.0%	+40.9%	1.841%
8/16/2021	UBS Asset Management Americas Inc.	29,972	$0.82M	0.0%	+41.4%	0.060%
8/16/2021	Point72 Asset Management L.P.	896,400	$24.46M	0.1%	+104.1%	1.784%
8/16/2021	Cubist Systematic Strategies LLC	2,622	$72K	0.0%	-81.0%	0.005%
8/16/2021	California State Teachers Retirement System	38,143	$1.04M	0.0%	+9.4%	0.076%
8/16/2021	Morgan Stanley	226,673	$6.19M	0.0%	+80.3%	0.451%
8/16/2021	Credit Suisse AG	14,624	$0.40M	0.0%	-12.3%	0.029%
8/16/2021	Charles Schwab Investment Management Inc.	193,382	$5.28M	0.0%	+7.6%	0.385%
8/16/2021	State Street Corp	1,152,482	$31.45M	0.0%	+19.1%	2.294%
8/16/2021	Nuveen Asset Management LLC	263,846	$7.20M	0.0%	+18.3%	0.525%
8/16/2021	Goldman Sachs Group Inc.	31,759	$0.87M	0.0%	+48.4%	0.063%
8/16/2021	Marshall Wace LLP	15,138	$0.41M	0.0%	-91.1%	0.030%
8/13/2021	Northern Trust Corp	290,103	$7.92M	0.0%	+8.7%	0.577%

Data available starting January 2016

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Today's Range

Now: $21.49

$21.01

$22.18

50 Day Range

MA: $20.44

$16.33

$22.20

52 Week Range

Now: $21.49

$13.59

$27.53

Volume

13,997 shs

Average Volume

318,547 shs

Market Capitalization

$1.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.28

Who are the company insiders with the largest holdings of Arcutis Biotherapeutics?: Arcutis Biotherapeutics' top insider shareholders include:
Bhaskar Chaudhuri (Director)
Todd Franklin Watanabe (CEO)
Orbimed Advisors Llc (Major Shareholder)
David W Osborne (Insider)
Howard G Welgus (Director)
Masaru Matsuda (SVP)
David W Osborne (Insider)
Howard G Welgus (Director)
John W Smither (CFO)
Patricia A Turney (SVP)
Patrick Burnett (Insider)
Scott L Burrows (CFO)
Learn More about top insider investors at Arcutis Biotherapeutics.

What Investors Don't Know: Communist China Could Profit Billions From The World "Going Green."

From Investing Trends | Ad

Who controls 80% of the works lithium supply (the most important metal for building EV batteries)? China! And if you're outraged by that fact, then you'll love hearing how this western company is fighting back…

See How This Lithium Play Could Explode